Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 40 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Dereje A. N.

United States

USD 40 /hr

Biostatistician with Background in Drug Development & Clinical Research

Profile Summary

I am a PhD-trained medical scientist and experienced biostatistician with a strong background in clinical research, drug discovery, and data analysis. I hold a PhD in Medical Sciences, a Master’s in Health Informatics and Data Analytics, and certified in ACRP-CP. Over the past decade, I’ve contributed to more than 20 peer-reviewed publications, collaborating on projects ranging from infectious diseases to clinical trials and population health. Currently working as a hospital-based biostatistician, I support retrospective and prospective studies, perform statistical modeling, and develop analytic reports for clinical and academic stakeholders. My technical skills include R, SPSS, SAS, and advanced statistical techniques such as survival analysis, regression modeling, and propensity score matching. I’m available for part-time, freelance, or contract-based biostatistics support—particularly in the areas of clinical data analysis, study design consultation, and manuscript preparation.

Subject Matter Expertise

• ☆ Biostatistics
• ☆ Data Analysis
• ☆ Drug Discovery
• ☆ Drug Target Identification
• ☆ Public Health
• ☆ Epidemiology
• ☆ Health Informatics

Services

• Consulting

Consulting Operations Consulting, Scientific and Technical Consulting

Work Experience

Biostatistician

St Luke University Health Network

June 2025 - Present

Hackensack University Medical Center

September 2019 - Present

Education

Masters of Science in Health Informatics and Data Analytics

University of Arizona Global Campus

December 2023 - July 2025

PhD (Medicine )

National University of Singapore

January 2015 - July 2019

Certifications

• Association of Clinical Research Professionals - Certified Professional

  Association of Clinical Research Professionals

  https://www.credly.com/badges/96b94fec-e8d0-4633-864c-251c15c7d9bb/linked_in?t=ssaur9

  February 2025 - Present

Publications

JOURNAL ARTICLE

Dereje A. Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, Thomas Dick, Jared A. Silverman (2024). A pairwise approach to revitalize β-lactams for the treatment of TB . Antimicrobial Agents and Chemotherapy.

Dereje A Negatu, Sung Jae Shin, Su-Young Kim, Byung Woo Jhun, Véronique Dartois, Thomas Dick (2023). Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease . The Journal of Infectious Diseases.

Dereje A. Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, Thomas Dick, Gyanu Lamichhane (2023). Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus . Microbiology Spectrum.

Dereje A. Negatu, Wassihun Wedajo Aragaw, Julianna Cangialosi, Véronique Dartois, Thomas Dick (2023). Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections . Antimicrobial Agents and Chemotherapy.

Dereje A. Negatu, Rubén González del Río, Mónica Cacho-Izquierdo, David Barros-Aguirre, Joël Lelievre, Joaquín Rullas, Patricia Casado, Uday S. Ganapathy, Matthew D. Zimmerman, Martin Gengenbacher, et al. (2023). Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection . Antimicrobial Agents and Chemotherapy.

Dereje Abate Negatu and Andreas Beuchel and Abdeldjalil Madani and Nadine Alvarez and Chao Chen and Wassihun Wedajo Aragaw and Matthew D. Zimmerman and Beno{\^{\i}}t Laleu and Martin Gengenbacher and V{\'{e}}ronique Dartois and Peter Imming and Thomas Dick(2021). Piperidine-4-carboxamides target DNA gyrase in Mycobacterium abscessus . Antimicrobial Agents and Chemotherapy. American Society for Microbiology

Dereje Abate Negatu and Martin Gengenbacher and V{\'{e}}ronique Dartois and Thomas Dick(2020). Indole Propionic Acid, an Unusual Antibiotic Produced by the Gut Microbiota, With Anti-inflammatory and Antioxidant Properties . Frontiers in Microbiology. 11. Frontiers Media {SA}

Dereje Abate Negatu, Yoshiyuki Yamada, Yu Xi, Mei Lin Go, Matthew Zimmerman, Uday Ganapathy, Véronique Dartois, Martin Gengenbacher, Thomas Dick, Mary Jackson, et al.(2019). Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis . mBio. 10. (2). American Society for Microbiology

(2017). Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular . Antimicrobial Agents and Chemotherapy.

(2014). Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

(2012). Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia . BMC Research Notes.